Cowen & Co Initiates Coverage on Qiagen (QGEN) with an Outperform
More News related to QGEN
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Xenomics, Inc. and Its Subsidiary TrovaGene, Inc. Announce HPV Patent Filing Based on Transrenal DNA Technology
- Qiagen NV (QGEN) Posts Q3 EPS of $0.26, Tops by 3c; Raises FY09 EPS
- QIAGEN Reports Strong Third Quarter 2009 Results
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
More News related to New Coverage
- TransCanada (TRP) Awards Mitsubishi Heavy Industries with 900MW Gas Turbine Order
- Spectrum Pharma (SPPI) Phase 3 Apaziquone Enrollment Complete
- Clarient (CLRT) GIven Exclusive Rights to Develop and Commercialize MUC1 Protein
- Rovi (ROVI) Patents Infringed by Virgin Media
Cowen & Co initiates coverage on Qiagen (Nasdaq: QGEN) with an Outperform rating.
To see more analyst ratings on QGEN Click Here.
Qiagen N.V. provides technologies and products for preanalytical sample preparation and linked molecular assay solutions worldwide.
Related Categories
New CoverageStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
